Dashboard
Manage Tickers

GSKGSK plc

NYSE gsk.com


$ 44.25 $ -0.88 (-1.95 %)    

Tuesday, 28-May-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 1.73 (0.38 %)
DIA $ 398.57 $ -2.04 (-0.52 %)
SPY $ 530.36 $ 0.37 (0.07 %)
TLT $ 91.26 $ -1.31 (-1.43 %)
GLD $ 225.37 $ 2.27 (1.05 %)
$ 44.24
$ 44.72
$ 0.00 x 0
$ 0.00 x 0
$ 44.24 - $ 44.72
$ 31.77 - $ 45.80
2,647,350
na
95.38B
$ 0.52
$ 15.19
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
CureVac Has Dosed The First Participant In...
05/28/2024 11:17:48

astrazeneca-merck-gsk-struck-record-441b-licensing-deals-with-chinese-drugmakers-in-2023-report
AstraZeneca, Merck, GSK Struck Record $44....
05/27/2024 11:12:58

Western pharmaceutical companies and investors are driving a record number of licensing deals with Chinese drugmakers.

zantac-verdict-jury-finds-no-link-to-colon-cancer-in-initial-trial-gsk-and-boehringer-prevail-in-first-zantac-cancer-lawsuit
Zantac Verdict: Jury Finds No Link To Colo...
05/24/2024 17:45:32

Chicago jury rejects woman's claim that Zantac caused her colon cancer. First of thousands of similar lawsuits, companies d...

jury-rules-zantac-not-a-cause-of-womans-cancer-in-first-trial-over-drug
Jury Rules Zantac Not A Cause Of Woman's C...
05/23/2024 17:02:34

- Reuters

first-advanced-oral-treatment-for-asthma---sanofis-investigational-drug-shows-potential
First Advanced Oral Treatment For Asthma -...
05/22/2024 17:59:47

Sanofi reveals Phase 2 results for rilzabrutinib in moderate-to-severe asthma. High and low doses showed a reduction in asthma ...

gsk-concealed-risk-associated-with-discontinued-heart-burn-drug-zantac-whistleblower-lawsuit-claims
GSK Concealed Risk Associated With Discont...
05/21/2024 16:48:38

Valisure sues GSK accusing the company of hiding cancer risks linked to Zantac, potentially defrauding the U.S. government. Thi...

gsks-experimental-asthma-drug-reduces-severe-attacks-phase-3-trial-data-shows
GSK's Experimental Asthma Drug Reduces Sev...
05/21/2024 12:31:32

GSK announced results from phase 3 trials SWIFT-1 and SWIFT-2, showing depemokimab's efficacy and safety in reducing severe...

gsks-phase-3-trials-swift-1-and-swift-2-of-depemokimab-versus-placebo-in-severe-asthma-patients-with-type-2-inflammation-met-primary-endpoints-of-reduction-in-annualized-rate-of-clinically-significant-exacerbations-asthma-attacks-over-52-weeks
GSK's Phase 3 Trials SWIFT-1 and SWIFT-2 O...
05/21/2024 09:37:38

gsk-faces-whistleblower-suit-from-lab-that-exposed-zantac-risk-wisner-moore-to-represent-valisure-in-case-valisure-claims-gsk-hid-drug-risks-while-us-paid-for-zantac
GSK Faces Whistleblower Suit From Lab That...
05/20/2024 17:53:58

-Bloomberg

gsk-completely-exits-sensodyne-toothpaste-maker-haleon-in-16b-sale
GSK Completely Exits Sensodyne Toothpaste ...
05/17/2024 14:45:21

GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advi...

Core News & Articles
GSK Announces Intention To Sell ~385M Shar...
05/16/2024 15:44:29

GSK plc (LSE/NYSE: GSK) today announced that it intends to sell approximately 385m ordinary shares in Haleon, equivalent to app...

pfizer-astrazeneca-sanofi-and-mainz-biomed-to-uplevel-europes-pharma-game
Pfizer, AstraZeneca, Sanofi And Mainz Biom...
05/16/2024 12:51:36

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will...

Core News & Articles
ViiV Healthcare Says Health Canada Approve...
05/13/2024 12:10:28

Approved for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV infection in at-risk adults and adoles...

amazon-pours-13b-investment-into-french-operations-report
Amazon Pours ~$1.3B Investment Into French...
05/13/2024 10:20:44

Amazon's €1.2 billion investment marks a significant stride in bolstering its French presence, promising 3,000 new jobs. Th...

fda-delays-important-moderna-vaccine-review-william-blair-says-2025-growth-2026-breakeven-story-depends-on-it
FDA Delays 'Important' Moderna Vaccine Rev...
05/10/2024 13:27:05

FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.

top-5-health-care-stocks-that-could-sink-your-portfolio-in-q2
Top 5 Health Care Stocks That Could Sink Y...
05/09/2024 12:44:39

pfizer-agrees-to-settle-over-10000-lawsuits-about-cancer-risks-associated-with-discontinued-heartburn-drug-zantac
Pfizer Agrees To Settle Over 10,000 Lawsui...
05/08/2024 18:58:30

Pfizer settles 10,000 Zantac lawsuits over cancer risks, but challenges remain. Details undisclosed. Sanofi's $100 million+...

bioversys-and-gsk-boost-fight-against-tuberculosis-with-expanded-partnership-and-series-c-funding-increase-by-chf-123m
BioVersys And GSK Boost Fight Against Tube...
05/07/2024 06:18:35

Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosis ...

gsk-sees-strong-demand-for-vaccines-and-asthma-drugs-raises-annual-outlook
GSK Sees Strong Demand For Vaccines and As...
05/01/2024 13:42:17

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Sp...

wall-street-set-to-open-lower-after-amd-earnings-disappoint-as-traders-look-to-feds-powell-for-relief-why-this-analyst-sees-incoming-summer-rally
Wall Street Set To Open Lower After AMD Ea...
05/01/2024 10:44:10

A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION